MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Reliability of Continuous Parkinson’s Assessment Using Wearables

D. Heldman, E. Urrea Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, A. Hadley, Z. Mari, M. Burack, I. Itin, F. Revilla (Cleveland, OH, USA)

Meeting: 2017 International Congress

Abstract Number: 655

Keywords: Bradykinesia, Dyskinesias, Tremors: Clinical features

Session Information

Date: Tuesday, June 6, 2017

Session Title: Technology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To evaluate test-retest reliability and determine the optimal number of days of use for wearable sensors and a mobile software app to continuously and objectively assess Parkinson’s disease (PD) during activities of daily living.  

Background: Consumer wearables linked with smartphone apps are becoming increasingly common to assess PD. Determining test-retest reliability and providing guidance for balancing patient burden and number of days of use required to obtain clinically significant results is essential for validation.

Methods: Thirteen adults (Age 53-74) with PD and at least two hours of OFF time and/or one hour of troublesome dyskinesia participated in a 5-month study. Participants were trained to don motion sensors on the wrist and ankle and use a smartphone app to start/stop data collection. Participants were instructed to use the system throughout the waking day for blocks of four consecutive days during the first week, third week, and each of months 2-5. At the end of each day of use, participants removed the sensors for wireless recharging and data upload to a server for processing into metrics quantifying tremor, dyskinesia, slowness, and gait throughout the day using previously validated algorithms. Intraclass correlation (ICC) and minimal detectable change (MDC) were calculated between weeks 1 and 3 when averaging 1, 2, 3, and 4 days of collected data.

Results: For each block a participant used the device for at least one day, compliance for 2, 3, and 4 days was 100%, 92%, and 84%, respectively. Average ICCs were 0.74, 0.80, 0.88, and 0.94 when including 1, 2, 3, and 4 days of data, respectively, while average MDCs were 22.4, 16.9, 13.2, and 10.1 (percent full scale).

Conclusions: Reliability and sensitivity improved with increasing number of days of use; however, so did patient burden. Three days of use may provide an optimal compromise to minimize patient burden without sacrificing reliability. 

References: A version of this abstract was submitted to be presented at the American Academy of Neurology 2017 Annual Meeting. 

To cite this abstract in AMA style:

D. Heldman, E. Urrea Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, A. Hadley, Z. Mari, M. Burack, I. Itin, F. Revilla. Reliability of Continuous Parkinson’s Assessment Using Wearables [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/reliability-of-continuous-parkinsons-assessment-using-wearables/. Accessed July 10, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/reliability-of-continuous-parkinsons-assessment-using-wearables/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley